“…Nucleotide-based adjuvants (e.g., synthetic double-stranded RNA polyriboinosinic acid-polyribocytidylic acid [poly (I:C)], cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN), and cyclic guanosine monophosphate-adenosine monophosphate (2′3′-cGAMP or cGAMP)) are, on the other hand, target-specific molecules. For instance, poly (1:C), CpG ODN, and cGAMP specifically interact with Toll-like receptor (TLR) 3, TLR9, and stimulator of interferon genes (STING) receptors, respectively, activating inflammatory cytokines and type 1 interferon, eventually stimulating both innate and adaptive immune responses [ 301 , 302 , 303 , 304 , 305 , 306 ].…”